1993
DOI: 10.1159/000173753
|View full text |Cite
|
Sign up to set email alerts
|

Metabolism of Dexamethasone: Sites and Activity in Mammalian Tissues

Abstract: We have used in vitro techniques to study the metabolism of dexamethasone. Tissue slices, homogenates and microsomal fractions of various mammalian organs from rats and humans have been used. We focused particularly on the question of whether or not dexamethasone (Dexa) is oxidized at the C11-OH group by 11β-hydroxysteroid-dehydrogenase. High activities of this enzyme system for Dexa were localized in renal cortex and rectum. Material from both human and murine liver was ineffective. The main metabolite formed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
24
0
1

Year Published

1996
1996
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(27 citation statements)
references
References 22 publications
2
24
0
1
Order By: Relevance
“…Both dexamethasone and cortisol are able to cross the placenta in rats (8,40,46,58) and sheep (16,17,35) and lead to adverse outcomes for adult offspring, but the extent to which each glucocorticoid actually crosses the placenta into the fetal circulation and accesses fetal tissues in early gestation is unknown. Dexamethasone is poorly metabolized by 11␤-HSD-2 and, therefore, most readily crosses the placenta (11,59). Therefore, it seemed likely that the placenta and fetal tissues would have a greater glucocorticoid exposure following dexamethasone compared with cortisol in the present study.…”
Section: Discussionmentioning
confidence: 84%
“…Both dexamethasone and cortisol are able to cross the placenta in rats (8,40,46,58) and sheep (16,17,35) and lead to adverse outcomes for adult offspring, but the extent to which each glucocorticoid actually crosses the placenta into the fetal circulation and accesses fetal tissues in early gestation is unknown. Dexamethasone is poorly metabolized by 11␤-HSD-2 and, therefore, most readily crosses the placenta (11,59). Therefore, it seemed likely that the placenta and fetal tissues would have a greater glucocorticoid exposure following dexamethasone compared with cortisol in the present study.…”
Section: Discussionmentioning
confidence: 84%
“…These patterns are also evident when low dexamethasone doses are administered (14). The activity of the 11␤-hydroxysteroid dehydrogenase type 1 and 2, which catalyze not only the reversible interconversion of cortisol to cortisone (34) but also that of dexamethasone to 11-dehydrodexamethasone (35,36) may explain the difference between the sexes. Previous studies have shown that obesity and gender may have different effects on 11␤-hydroxysteroid dehydrogenase activity and, consequently, on cortisol concentrations (37,38) and HPA axis responsiveness to CRH and AVP (8).…”
Section: Discussionmentioning
confidence: 99%
“…Dies ist von erheblicher Relevanz, da derzeit fast 10% aller Schwangeren im letzten Drittel der Schwangerschaft mit synthetischen Glukokortikoiden aufgrund einer vermeintlichen oder tatsächlichen Gefahr einer Früh-geburt behandelt werden. Synthetische Glukokortikoide wie Betamethason und Dexamethason sind potenziell besonders effektiv bei der akuten Veränderung des Funktionszustandes des fetalen Gehirns und der Programmierung affektiver Störungen und neuropsychologischer Auffälligkeiten im späteren Leben, da das plazentare Enzym 11 ␤ -HSD2, das den Übertritt von Glukokortikoiden in die fetale Zirkulation reguliert, nur eine niedrige Affinität zu synthetischen Glukokortikoiden hat, sodass diese nahezu ungehindert in die fetale Zirkulation überge-hen [113][114][115] . Tatsächlich hat bereits eine einmalige prä-natale Glukokortikoidbehandlung akute und chronische Effekte auf die Hirnfunktion.…”
Section: Akute Effekte Einer Pränatalen Glukokortikoidtherapieunclassified